MedPath

The use of the Airdrive* machine perfusion system in graft preservation during kidney transplantation: a pilot study in kidney transplantation of grafts from post-mortem donors.

Completed
Conditions
Kidney transplantation for kidney failure
10038365
Registration Number
NL-OMON42777
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
7
Inclusion Criteria

Patients eligble for kidney transplantation from a post-mortem donor, who are at least 18 years of age and mentally competent.

Exclusion Criteria

Patient is mentally incompetent and/or has an age of 17 or less.
The time between arrival of the graft in the AMC and the transplantation into the patient is expected to be less than 2 hours, as estimated by the transplant surgeon or surgical resident.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study endpoint is the absence of adverse effects due to the use of<br /><br>Airdrive* machine perfusion as preservation method. Every unexpected event<br /><br>possibly related to the use of the Airdrive* that occurs during the<br /><br>transplantation procedure or within 1-month follow-up, will be evaluated<br /><br>(perioperative cardiovascular incidents, haematological abnormalities,<br /><br>postoperative infections and clinical parameters).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints comprise perfusion parameters, which are recorded as part<br /><br>of the Airdrive* system.</p><br>
© Copyright 2025. All Rights Reserved by MedPath